Molecular studies of alpha-2-adrenoceptor and catecholamine-insensitive imidazoline-receptor binding sites using [3H]-rilmenidine in rat brain and kidney.
King
P R
PR
University of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.
Suzuki
S
S
Nero
T L
TL
Gundlach
A L
AL
Louis
W J
WJ
D000316:Adrenergic alpha-Agonists / Q000378:metabolism; D000818:Animals; D000959:Antihypertensive Agents / Q000378:metabolism; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D054755:Imidazoline Receptors; D066298:In Vitro Techniques; D007668:Kidney / Q000378:metabolism; D010080:Oxazoles / Q000378:metabolism*; D051381:Rats; D018341:Receptors, Adrenergic, alpha-2 / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*; D000077769:Rilmenidine; D014018:Tissue Distribution
D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D002395:Catecholamines; D054755:Imidazoline Receptors; D010080:Oxazoles; D018341:Receptors, Adrenergic, alpha-2; D011955:Receptors, Drug; D000077769:Rilmenidine